PharmaCyte Biotech, Inc.
PMCB
$1.04
$0.032.97%
NASDAQ
07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
---|---|---|---|---|---|
Net Income | -8.36M | 11.75M | -3.05M | -1.47M | 23.42M |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 7.32M | -14.05M | 2.11M | 864.20K | -23.92M |
Change in Net Operating Assets | -954.80K | 1.26M | 422.20K | -449.30K | 125.70K |
Cash from Operations | -1.99M | -1.04M | -509.90K | -1.05M | -373.30K |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | -7.00M |
Cash from Investing | -- | 0.00 | 0.00 | 0.00 | -7.00M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -171.50K | -225.00K | -1.40M | -742.20K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | 0.00 | -3.72M | -9.34M | -9.43M |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -- | -171.50K | -3.95M | -10.74M | -10.17M |
Foreign Exchange rate Adjustments | 100.00 | 600.00 | -1.20K | 100.00 | 200.00 |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -1.99M | -1.21M | -4.46M | -11.80M | -17.54M |